FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088098100> ?p ?o ?g. }

• W2088098100 endingPage "125" @default.
• W2088098100 startingPage "119" @default.
• W2088098100 abstract "This study compared the effects of a thromboxane synthase inhibitor, thromboxane receptor antagonist, and cyclooxygenase inhibitor in a canine arterial graft patency model. Fifty-six dogs were divided into a control (no treatment) and five treatment groups: thromboxane synthase inhibitor (U63557A; 15 mg/kg/tid); thromboxane receptor antagonist (SQ29548; 0.02 mg/kg/hr); high-dose aspirin (325 mg/day; low-dose aspirin (1 mg/kd/day; and aspirin plus dipyridamole (325 mg/day aspirin; 3 mg/kg/day dipyridamole). Drugs were orally administered except for thromboxane receptor antagonist, which was delivered intravenously by minosmotic pumps. After 24 hours of drug treatment, bilateral femoral artery prosthetic grafts (4 mm diameter × 7 cm; 1 polytetrafluoroethylene and 1 Dacron) were implanted. Patency was determined after 1 week. Dogs were classified before operation according to their epinephrine-enhanced arachidonate-stimulated platelet aggregation response. Polytetrafluoroethylene and Dacron graft patency rates were equivalent in all groups. Overall graft patency was significantly improved from 42% (control) to 94% by both high-dose aspirin and thromboxane receptor antagonist (p < 0.001). Aspirin-dipyridamole also improved patency (83%; p < 0.01 versus control), whereas thromboxane synthase inhibitor and low-dose aspirin were not effective. Baseline platelet aggregation was not predictive of patency. The drugs that promoted graft patency in this model either suppressed both thromboxane A2 and prostaglandin H2 formation (high-dose aspirin) or blocked their combined platelet receptor (thromboxane receptor antagonist). Thromboxane synthase inhibitor may be ineffective because prostaglandin H2 production is allowed. These data suggest that activation of the platelet thromboxane A2-prostaglandin H2 receptor is an essential event in early arterial graft thrombosis. (J VASC SURG 1990;12:119-25.)" @default.
• W2088098100 created "2016-06-24" @default.
• W2088098100 creator A5029652042 @default.
• W2088098100 creator A5032061665 @default.
• W2088098100 creator A5044493690 @default.
• W2088098100 creator A5053275481 @default.
• W2088098100 creator A5078158807 @default.
• W2088098100 date "1990-08-01" @default.
• W2088098100 modified "2023-09-26" @default.
• W2088098100 title "The effect of thromboxane receptor blockade versus thromboxane synthase inhibition on canine arterial graft patency" @default.
• W2088098100 cites W1963860018 @default.
• W2088098100 cites W1966682207 @default.
• W2088098100 cites W1981297752 @default.
• W2088098100 cites W1998223532 @default.
• W2088098100 cites W2000089519 @default.
• W2088098100 cites W2012241915 @default.
• W2088098100 cites W2015705080 @default.
• W2088098100 cites W2019813800 @default.
• W2088098100 cites W2020005976 @default.
• W2088098100 cites W2047655922 @default.
• W2088098100 cites W2047894969 @default.
• W2088098100 cites W2049030348 @default.
• W2088098100 cites W2066559265 @default.
• W2088098100 cites W2087186913 @default.
• W2088098100 cites W2110341188 @default.
• W2088098100 cites W2118145139 @default.
• W2088098100 cites W2123520002 @default.
• W2088098100 cites W2125415613 @default.
• W2088098100 cites W2131164001 @default.
• W2088098100 cites W2150954483 @default.
• W2088098100 cites W2151875550 @default.
• W2088098100 cites W2163931773 @default.
• W2088098100 cites W2317069681 @default.
• W2088098100 cites W2421646572 @default.
• W2088098100 cites W2432053348 @default.
• W2088098100 cites W2472542224 @default.
• W2088098100 doi "https://doi.org/10.1016/0741-5214(90)90099-v" @default.
• W2088098100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2143235" @default.
• W2088098100 hasPublicationYear "1990" @default.
• W2088098100 type Work @default.
• W2088098100 sameAs 2088098100 @default.
• W2088098100 citedByCount "12" @default.
• W2088098100 countsByYear W20880981002019 @default.
• W2088098100 countsByYear W20880981002021 @default.
• W2088098100 countsByYear W20880981002022 @default.
• W2088098100 crossrefType "journal-article" @default.
• W2088098100 hasAuthorship W2088098100A5029652042 @default.
• W2088098100 hasAuthorship W2088098100A5032061665 @default.
• W2088098100 hasAuthorship W2088098100A5044493690 @default.
• W2088098100 hasAuthorship W2088098100A5053275481 @default.
• W2088098100 hasAuthorship W2088098100A5078158807 @default.
• W2088098100 hasConcept C126322002 @default.
• W2088098100 hasConcept C134018914 @default.
• W2088098100 hasConcept C170493617 @default.
• W2088098100 hasConcept C173202427 @default.
• W2088098100 hasConcept C181199279 @default.
• W2088098100 hasConcept C185592680 @default.
• W2088098100 hasConcept C2776785769 @default.
• W2088098100 hasConcept C2776885963 @default.
• W2088098100 hasConcept C2776890861 @default.
• W2088098100 hasConcept C2777628954 @default.
• W2088098100 hasConcept C2778122271 @default.
• W2088098100 hasConcept C2779689624 @default.
• W2088098100 hasConcept C2781024287 @default.
• W2088098100 hasConcept C2781080829 @default.
• W2088098100 hasConcept C42219234 @default.
• W2088098100 hasConcept C51603380 @default.
• W2088098100 hasConcept C55493867 @default.
• W2088098100 hasConcept C71924100 @default.
• W2088098100 hasConcept C89560881 @default.
• W2088098100 hasConcept C98274493 @default.
• W2088098100 hasConceptScore W2088098100C126322002 @default.
• W2088098100 hasConceptScore W2088098100C134018914 @default.
• W2088098100 hasConceptScore W2088098100C170493617 @default.
• W2088098100 hasConceptScore W2088098100C173202427 @default.
• W2088098100 hasConceptScore W2088098100C181199279 @default.
• W2088098100 hasConceptScore W2088098100C185592680 @default.
• W2088098100 hasConceptScore W2088098100C2776785769 @default.
• W2088098100 hasConceptScore W2088098100C2776885963 @default.
• W2088098100 hasConceptScore W2088098100C2776890861 @default.
• W2088098100 hasConceptScore W2088098100C2777628954 @default.
• W2088098100 hasConceptScore W2088098100C2778122271 @default.
• W2088098100 hasConceptScore W2088098100C2779689624 @default.
• W2088098100 hasConceptScore W2088098100C2781024287 @default.
• W2088098100 hasConceptScore W2088098100C2781080829 @default.
• W2088098100 hasConceptScore W2088098100C42219234 @default.
• W2088098100 hasConceptScore W2088098100C51603380 @default.
• W2088098100 hasConceptScore W2088098100C55493867 @default.
• W2088098100 hasConceptScore W2088098100C71924100 @default.
• W2088098100 hasConceptScore W2088098100C89560881 @default.
• W2088098100 hasConceptScore W2088098100C98274493 @default.
• W2088098100 hasIssue "2" @default.
• W2088098100 hasLocation W20880981001 @default.
• W2088098100 hasLocation W20880981002 @default.
• W2088098100 hasOpenAccess W2088098100 @default.
• W2088098100 hasPrimaryLocation W20880981001 @default.
• W2088098100 hasRelatedWork W1987288759 @default.
• W2088098100 hasRelatedWork W2022388431 @default.

• next